Home > Investing > Companies

Pharming

Price
 
Price € 0,04
Change € 0,00
Change % 4,76%
Open € 0,04
High € 0,04
Low € 0,04
Volume 343.100
Profile
 
Profile: Pharming is an innovative biotechnology company that has the mission to create value for all shareholders through the development of therapeutic products for humans. Pharming's goal is the development and commercialization of therapeutic proteins for difficult to treat or non-treatable diseases, thus helping patients and add value for shareholders. The developed applications can be applied in the case of genetic anomalies or use in resolving tissue damage after surgery. The current focus of Pharming is on product innovation. Future growth of the company is pursued through licensing products, its technology and strategic transactions.
Site: http://www.pharming.com
Industry: Biotechnology
Description: Companies in the biotechnology industry are performing research and development activities for the purpose of discovering new drugs and diagnostics. The turnover of these companies comes from sales of these products or the sale of licenses of drugs and diagnostic to other companies.
2011
 

Profit and loss

Net profit (x 1 mln) € -17,10 Turnover (x 1 mln) € 3,20
Cashflow (x 1 mln) Tooltip € -15,35 Net cashflow (x 1 mln) Tooltip € -17,37

Balance

Private equity (x 1 mln) € -1,19 Foreign equity (x 1 mln) € 25,88
Current assets (x 1 mln) € 13,16 Current liabilities (x 1 mln) € 8,14
Working capital (x 1 mln) € 5,03 Balance total (x 1 mln) € 24,69

Share

Outstanding shares (x 1 mln) 470,224 Price year-end € 0,08
Dividend per share - Earnings per share € -0,04
Dividend yield - Cashflow per share € -0,03
Intrinsic value € -0,00 Net cashflow per share € -0,04
Price/intrinsic value -31,665

Key figures

Price/earnings -2,199 Price/cashflow -2,450
Price/net cashflow -2,165 Stockmarket value (x 1 mln) € 37,62
Solvability Tooltip -0,048 Solvability Tooltip 0,954
Return on private equity 1.439,73% Return on total equity -69,26%
Current ratio 1,618 Market value/PE -31,665
Market value/turnover 11,774 Enterprise value/turnover 10,201
History
 
Year 2011 2010 2009 2008 2007
Net profit (x 1 mln) € -17,10 € -50,22 € -32,06 € -25,99 € -35,61
Turnover (x 1 mln) € 3,20 € 1,76 € 1,10 € 0,64 € 0,69
Price year-end € 0,08 € 0,21 € 0,45 € 0,64 € 1,32
Year high € 0,21 € 0,50 € 0,88 € 1,39 € 4,31
Year low € 0,08 € 0,14 € 0,32 € 0,55 € 0,81
Outstanding shares (x 1 mln) 470,224 266,313 116,178 91,658 90,913
Price/earnings -2,199 -1,114 -1,631 -2,257 -3,370
Earnings per share € -0,04 € -0,19 € -0,28 € -0,28 € -0,39
Dividends - - - - -
Dividend yield - - - - -
Pay out - - - - -
Private equity (x 1 mln) € -1,19 € 10,86 € 13,31 € 13,47 € 34,69
PE per share € -0,00 € 0,04 € 0,11 € 0,15 € 0,38
Balance total (x 1 mln) € 24,69 € 37,29 € 55,88 € 67,16 € 114,35
Stockmarket value (x 1 mln) € 37,62 € 55,93 € 52,28 € 58,66 € 120,01
Number of employees 86 86 77 81 81